Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1H-imidazol-2-yl)-3-alkyl-1Hpyrazole derivatives
Details for Australian Patent Application No. 2004230326 (hide)
International Classifications
Event Publications
3 November 2005 PCT application entered the National Phase
PCT publication WO2004/092159 Priority application(s): WO2004/092159
12 November 2009 Application Accepted
Published as AU-B-2004230326
4 March 2010 Opposition Lodged
Merial Ltd has lodged an opposition against Evultis.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004230328-Tumor antigens BFA5 for prevention and/or treatment of cancer
2004230316-Alpha substituted carboxylic acid as PPAR modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser